Correlation between the mRNA levels of BCRP and LUNX genes and pathological types and stages of patients with non-small cell lung cancer.
10.3760/cma.j.cn511386-20210624-00538
- Author:
Dong CHEN
1
;
Wenjie HAN
;
Pei WANG
;
Hongbin MA
Author Information
1. Department of Cardiothoracic Surgery, Huaihe Hospital of Henan University, Kaifeng, Henan 475000, China. chendong0373@yeah.net.
- Publication Type:Journal Article
- MeSH:
Humans;
ATP Binding Cassette Transporter, Subfamily G, Member 2/genetics*;
Biomarkers, Tumor/genetics*;
Carcinoma, Non-Small-Cell Lung/pathology*;
Glycoproteins/genetics*;
Lung Neoplasms/pathology*;
Lymphatic Metastasis;
Neoplasm Proteins/genetics*;
Phosphoproteins/genetics*;
Prognosis;
RNA, Messenger/genetics*
- From:
Chinese Journal of Medical Genetics
2023;40(2):202-207
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To analyze the correlation between the mRNA levels of breast cancer resistance protein (BCRP) and lung-specific X protein (LUNX) genes with pathological types and stages of patients with non-small cell lung cancer (NSCLC) and their significance for prognosis.
METHODS:Eighty nine patients with NSCLC admitted to Huaihe Hospital of Henan University between June 2015 and June 2018 were recruited, with 55 patients with benign lung lesions admitted during the same period of time selected as the control group. The mRNA levels of BCRP and LUNX genes were detected in the peripheral blood samples from the two groups, and their correlation with the clinicopathological characteristics and prognosis of the patients was analyzed.
RESULTS:The expression rates of BCRP and LUNX mRNA in the NSCLC group were significantly higher compared with the control group (P < 0.05). The level of BCRP mRNA of the NSCLC patients has correlated with the degree of differentiation and TNM staging (P < 0.05), but not with gender, age, smoking, pathological types and lymph node metastasis (P > 0.05). The level of LUNX mRNA of them has correlated with the degree of differentiation, TNM staging and lymph node metastasis (P < 0.05), but not with gender, age, smoking, and pathological types (P > 0.05). Compared with those with no expression, the overall survival rate of patients with BCRP and LUNX expression was significantly lower (P < 0.05). The degree of differentiation, TNM staging, lymph node metastasis, and expression of the BCRP and LUNX mRNA may all affect the prognosis of the patients.
CONCLUSION:The levels of BCRP and LUNX mRNA in the peripheral blood of patients with NSCLC are significantly increased. The expression of BCRP mRNA is correlated with the degree of differentiation and TNM staging, whilst the expression of LUNX mRNA is correlated with the differentiation degree, TNM staging and lymph node metastasis. Both may be used as independent predictors for the prognosis of patients with NSCLC.
